Utility of crossover designs in clinical trials: Efficacy of desipramine
vs. placebo in opioid - dependent cocaine abusers.
Furthermore, the effects of active
vs. placebo treatment on insulin sensitivity was compared.
This revealed significantly different changes in MCR after treatment (+27 %
vs. placebo; p <.01).
(wild blueberries
vs. placebo)
[10 - 12] In a recent gold - standard study, highly stressed patients receiving ashwaganda extract had significantly lower stress assessment scores
vs. their placebo controlled counterparts.
Using a variety of validated anxiety, stress, and depression scales, researchers reported significant improvements in day - to - day depression, anger, anxiety, as well as lower levels of the stress hormone cortisol among otherwise healthy adults taking a daily probiotic supplement
vs. placebo.
Lower inflammatory blood markers were also found but, to be fair, some of the improvements in arthritis scores were not much different
vs. placebo.
Risk of secondary cancers increased to 14.9 % vs. 8.8 % in those receiving lenalidomide
vs. placebo, including nonmelanoma skin cancers (3.9 % vs 2.6 %).
Phase 2 Randomized, Double - Blinded, Controlled Study of Tucatinib
vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2 + Breast Carcinoma
(A) SPM results for the comparison of MP
vs. placebo on the BPND images from [11C] raclopride in marijuana abusers (MA) and in healthy controls (HC)(Puncorr < 0.005) and group comparisons for the effects of MP (ΔBPND)(P < 0.01, cluster size of 10 voxels).
Greater efficacy was also seen for adalimumab
vs. placebo.
Stay tuned in 2016 for the results of UNLV placenta
VS. placebo study to be published!
«In order to be confident of the sensitivity of the study, we would expect to detect a difference between the «positive control» of caffeine
vs. placebo, consistent with the many previous investigations involving caffeine.
But even more amazing: For the next 12 weeks, both groups kept taking their pills (probiotics
vs. placebos), but without dieting... all the subjects were allowed to eat whatever they wanted.
Not exact matches
It may have to do with Addyi's high pricing (on par with Viagra at $ 26 per pill without an assistance program), its daily intake requirement (unlike Viagra, it adds up to $ 780 per month), its potentially deleterious side effects (low blood pressure and fainting), its restrictions on alcohol consumption (abstinence
vs. large quantities not recommended for Viagra patients), a 10 % efficacy rate (whereas Viagra works 50 % of the time compared to a
placebo, according to a recent study), and its subtle neurotransmitter - targeting mechanism (contrast that to the obvious hydraulics of Viagra).
The primary endpoint of death and non-fatal heart attack at 30 days was no different between the two groups (7 percent in the aspirin group and 7.1 percent in the
placebo group); however, major bleeding was significantly higher in aspirin - treated patients than in the
placebo group (4.6 percent
vs. 3.7 percent).
The annual rate of kidney enlargement was reduced by 66 % for patients receiving bosutinib 200 mg / day
vs. those receiving
placebo (1.63 %
vs. 4.74 %, respectively) and by 82 % for all patients receiving bosutinib
vs. those receiving
placebo (0.84 %
vs. 4.74 %, respectively).
The average spine BMD also increased more in the treatment group than
placebo group at 12 months (3 percent
vs. 1.1 percent) and at 24 months (4.5 percent
vs. 0.7 percent).
Nearly 40 % of patients in the active group,
vs. 6.3 % in the
placebo arm, achieved PASI 100 (completely clear skin) at week 24.
Randomized Phase II Study: Corticosteroids + Bevacizumab
vs. Corticosteroids +
Placebo (BEST) for Radionecrosis after Radiosurgery for Brain Metastases
The two groups were evenly matched with regard to rates of response to induction therapy (44 % complete or partial response in the pemetrexed arm
vs. 42 %
placebo arm).
Results of the CALGB 100104 trial yielded a median PFS of 5.7 years
vs. 1.9 years with
placebo.
IFM 2005 - 02 yielded a median PFS of 3.9 years
vs. 2 years with
placebo when lenalidomide was given as maintenance therapy.
The Shroom TECH Sport subjects statistically (p < 0.05) outperformed the
placebo group by getting three more reps (28
vs. 25) on the bench press when using 72.5 — 77.5 % of their one - rep maxes (1RM).
Pregnancy and delivery rates among the women receiving soy isoflavones was nearly double that of
placebo (30.3 %
vs. 15.2 %).
In same study on 36 test subjects with at least 3 years of weight training experience, subjects using the combination of creatine and whey gained 4 times the lean muscle than those using a
placebo (8.8
vs. 2.0 lbs.).
After supplementing with zinc (30 mg daily) for 2 months, women with PCOS saw slight improvements (12.5
vs. 8.3 %) in their acne compared to those who took a
placebo, according to a study in Biological Trace Elements Research.
1In a study on 46 subjects, individuals using a core ingredient in Six Star ® Joint & Muscle Recovery in combination with a training protocol significantly increased their range of motion on knee extensions compared to subjects using a
placebo (81
vs. 74 degrees).
There's a few studies like a few small studies that have found that compression garments increase performance when you wear them during exercise but they're typically with not a lot of subjects and they're really not the best studies on the face of the planet when it comes to for example the fact that none of the studies used the
placebo group or a control group so it was hard to tell if the increases were really from sale like compression gear or from the athletes say like perception of the compression gear like the fact the athlete knew that they were wearing the gear
vs. a control group that wasn't wearing the gear at all.
In a trial of dogs with allergic dermatitis, treatment success, as defined by owner - assessed decrease in pruritus, occurred in 67 percent of dogs treated with APOQUEL
vs. 29 percent of dogs treated with
placebo after one week of treatment.
In a clinical trial of dogs with atopic dermatitis, treatment success for pruritus occurred in a significantly greater percentage of the dogs treated with APOQUEL (66 percent)
vs. (4 percent) of dogs treated with
placebo (p < 0.0001).
Placebo vs. social learning effect in parent training procedures designed to alter the behaviour of aggressive boys